ANN D RHOADS Insider Trading Transactions
Get free email notifications about insider trading for ANN D RHOADS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANN D RHOADS. ANN D RHOADS is Director in NOVELLUS SYSTEMS INC ($NVLS) and Director in QUIDEL CORP /DE/ ($QDEL) and Director in IRIDEX CORP ($IRIX) and Director in GLOBUS MEDICAL INC ($GMED) and EVP, CFO, Treasurer & Sec. in ZOGENIX, INC. ($ZGNX) and Director in Evoke Pharma Inc ($EVOK) and Chief Financial Officer in Forty Seven, Inc. ($FTSV) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Repare Therapeutics Inc. ($RPTX).
Latest Insider Trading Transactions of ANN D RHOADS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EVOK, FTSV, GMED, IRIX, ITOS, NVLS, QDEL, RPTX, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Option Exercise | M | 0.00 | 624 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Buy | M | 0.00 | 624 | 0 | 624 | 0 to 624 |
May 14 2021 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
Mar 03 2021 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | M | 10.66 | 15,384 | 163,993 | 0 | |
Mar 03 2021 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Buy | M | 10.66 | 15,384 | 163,993 | 15,384 | 0 to 15.4 K |
Jan 19 2021 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 65.05 | 15,000 | 975,750 | 15,000 | |
Aug 26 2020 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Option Exercise | A | 0.00 | 624 | 0 | 624 | |
Aug 26 2020 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Option Exercise | A | 0.00 | 624 | 0 | 624 | |
Jul 24 2020 | ITOS | iTeos Therapeutics ... | RHOADS ANN D | Director | Option Exercise | A | 19.00 | 16,608 | 315,552 | 0 | |
Jun 25 2020 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Buy | P | 20.00 | 4,000 | 80,000 | 4,000 | 0 to 4 K |
Jun 19 2020 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 20.00 | 38,907 | 778,140 | 38,907 | |
May 29 2020 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 2.60 | 61,750 | 160,550 | 61,750 | |
May 29 2020 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 2.60 | 61,750 | 160,550 | 61,750 | |
Apr 07 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Option Exercise | D | 35.75 | 107,827 | 3,854,815 | 0 | |
Apr 07 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Option Exercise | D | 8.76 | 74,838 | 655,394 | 0 | |
Apr 07 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Option Exercise | D | 8.76 | 120,147 | 1,052,187 | 0 | |
Apr 07 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Sell | D | 0.00 | 37,414 | 0 | 0 | 37.4 K to 0 (-100.00 %) |
Apr 03 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Option Exercise | M | 8.76 | 20,950 | 183,470 | 120,147 | |
Apr 03 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Sell | S | 95.43 | 1,924 | 183,598 | 37,414 | 39.3 K to 37.4 K (-4.89 %) |
Apr 03 2020 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Buy | M | 8.76 | 20,950 | 183,470 | 39,338 | 18.4 K to 39.3 K (+113.93 %) |
Jan 24 2020 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 53.27 | 25,000 | 1,331,750 | 25,000 | |
Dec 17 2019 | FTSV | Forty Seven, Inc. | RHOADS ANN D | Chief Financial Off ... | Option Exercise | A | 35.75 | 107,827 | 3,854,815 | 107,827 | |
May 03 2019 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 0.72 | 36,500 | 26,280 | 36,500 | |
Feb 11 2019 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 43.58 | 25,000 | 1,089,500 | 25,000 | |
Jun 15 2018 | IRIX | IRIDEX CORP | RHOADS ANN D | Director | Grant | A | 0.00 | 5,690 | 0 | 5,690 | 0 to 5.7 K |
Jun 15 2018 | IRIX | IRIDEX CORP | RHOADS ANN D | Director | Grant | A | 0.00 | 5,690 | 0 | 5,690 | 0 to 5.7 K |
Jan 24 2018 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 43.77 | 25,000 | 1,094,250 | 25,000 | |
Aug 01 2017 | IRIX | IRIDEX CORP | RHOADS ANN D | Director | Option Exercise | M | 9.47 | 15,000 | 142,050 | 15,000 | |
May 05 2017 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 2.72 | 36,500 | 99,280 | 36,500 | |
Feb 01 2017 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 26.27 | 25,000 | 656,750 | 25,000 | |
Mar 16 2016 | ZGNX | ZOGENIX, INC. | RHOADS ANN D | EVP, CFO, Treasurer ... | Option Exercise | A | 10.35 | 60,000 | 621,000 | 60,000 | |
Apr 29 2016 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 4.81 | 21,500 | 103,415 | 21,500 | |
Jan 27 2016 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | Option Exercise | A | 25.52 | 20,000 | 510,400 | 20,000 | |
Oct 07 2015 | ZGNX | ZOGENIX, INC. | RHOADS ANN D | EVP, CFO, Treasurer ... | Option Exercise | A | 13.32 | 30,000 | 399,600 | 30,000 | |
Apr 24 2015 | EVOK | Evoke Pharma Inc | RHOADS ANN D | Director | Option Exercise | A | 6.43 | 9,000 | 57,870 | 9,000 | |
Mar 17 2015 | ZGNX | ZOGENIX, INC. | RHOADS ANN D | EVP, CFO, Treasurer ... | Option Exercise | A | 1.33 | 225,000 | 299,250 | 225,000 | |
Jun 06 2012 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Sell | D | 0.00 | 35,000 | 0 | 0 | 35 K to 0 (-100.00 %) |
May 13 2011 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
May 14 2010 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 30,000 | 25 K to 30 K (+20.00 %) |
May 14 2009 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 25,000 | 20 K to 25 K (+25.00 %) |
May 16 2008 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 20,000 | 15 K to 20 K (+33.33 %) |
May 16 2007 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
May 22 2006 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
May 04 2005 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Apr 20 2004 | NVLS | NOVELLUS SYSTEMS I ... | RHOADS ANN D | Director | Option Exercise | A | 31.72 | 18,000 | 570,960 | 18,000 |
Page: 1